Future Pak becomes exclusive U.S. marketer for Mytesi® and Canalevia®-CA1 Meaningful non-dilutive capital enables Jaguar to ...
CRMD's DefenCath, the only FDA-approved antimicrobial catheter lock, saw higher outpatient dialysis use in the fourth quarter ...
Up to additional $20M in milestone and other future payments Future Pak becomes exclusive U.S. marketer for Mytesi and Canalevia-CA1 Jaguar continues to be the manufacturer of Mytesi and Canalevia-CA1 ...
Biotin deficiency is a medical condition resulting from insufficient biotin that can lead to various clinical manifestations ...
In May 2022, The US FDA authorized the use of RADICAVA ORS (edaravone) in an oral formulation for the treatment of ALS.
On track to report interim results from approximately 25 six-month evaluable BCG-Unresponsive patients in ADVANCED-2 trial in Q1 2026Received ...
Detailed price information for Artara Therapeutics Inc (TARA-Q) from The Globe and Mail including charting and trades.
Chronic pain affects approximately 50 million Americans, and this therapy avoids addiction risks linked to narcotic ...
Looking for yoga classes, sound healing, and new ways to relax quickly and effectively – because that is what we all need right now, isn’t it?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback